• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …

Sinusoidal obstruction syndrome or veno-occlusive disease (SOS/VOD) is a potentially life-
threatening complication of hematopoietic SCT (HSCT). This review aims to highlight, on …

The major vascular disorders of the liver are listed in Table 2. Most of the vascular disorders
of the liver are rare, with the exception of portal vein thrombosis (PVT) in patients with …

Hepatic sinusoidal obstruction syndrome (SOS) is an obliterative venulitis of the terminal
hepatic venules, which in its more severe forms imparts a high risk of mortality. SOS, also …

Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome
(SOS), can develop in a subset of patients, primarily after myeloablative hematopoietic stem …

Hepatic veno-occlusive disease (VOD) or sinusoidal obstruction syndrome (SOS) is a rare
complication characterized by hepatomegaly, right-upper quadrant pain, jaundice, and …

Summary of Key Recommendations Diagnosis It is recommended that the diagnosis of veno‐
occlusive disease (sinusoidal obstruction syndrome)[VOD (SOS)] be based primarily on …

Importance Case reports and series suggest hematopoietic stem cell transplantation (HSCT)
may benefit some patients with Crohn disease. Objective To evaluate the effect of …

UDCA (ursodeoxycholic acid) is the therapeutic agent most widely used for the treatment of
cholestatic hepatopathies. Its use has expanded to other kinds of hepatic diseases, and …

Sinusoidal obstruction syndrome (SOS), also called veno‐occlusive disease of the liver, is
one of the most relevant complications of endothelial origin that appears early after …